Campbell & Co. Investment Adviser »

Y Mabs Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2M 76k 16.26

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Y Mabs Therapeutics

BlackRock
Paradigm Biocapital Advisors
Sofinnova Ventures
Vanguard Group
Polar Capital Holdings
Point72 Asset Management
D. E. Shaw & Co
State Street Corporation
Pictet Asset Management Holding SA
Geode Capital Management
Acadian Asset Management
Caligan Partners
Soleus Capital Management
Dimensional Fund Advisors
Goldman Sachs Group

View all funds holding Y Mabs Therapeutics